Predict your next investment

MedCircuit company logo
INTERNET | Internet Software & Services / Healthcare
medcircuit.com

See what CB Insights has to offer

Stage

Angel | Alive

Total Raised

$390K

Last Raised

$110K | 3 yrs ago

About MedCircuit

MedCircuit is an artificial intelligence triage software assisting doctors and nurses in the clinical setting to improve efficiency in both emergency medicine and general practice.

MedCircuit Headquarter Location

141 Plymouth Grove

Manchester, England, M13,

United Kingdom

+44 (0)203 488 1931

Latest MedCircuit News

MedCircuit secures funding for A&E software

May 15, 2018

Manchester-based healthcare technology startup MedCircuit has secured £153,000 investment from NPIF - Mercia Equity Finance. The business was founded in 2015 by NHS doctor Lanre Olaitan to assist nurses and doctors in A&E departments in the triage of patients. The software allows patients to check in using an iPad and asks them to provide details concerning their reason for attending A&E. It employs an algorithm and question tree approach to build additional information for the doctor. The aim is to improve efficiency through the reduction in the time doctors spend taking notes at the start of a consultation. The clinical information provided by patients via the software means the doctor can spend less time on patient history, focus on clinical examination and speed up consultations. This should allow patients to move through the system more quickly and help to reduce waiting times. The funding provided by NPIF - Mercia Equity Finance, which is managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund, will be used to further develop the software and to run trials across a number of UK hospitals. MedCircuit also secured a £50,000 grant from Innovate UK in 2017 and a further £80,000 investment from the Oxford Innovation Opportunity Network. The number of people attending A&E has increased substantially over the years. In 2017-18 there were 23.9m attendances at A&E departments in England (2016-17: 23.4m), with 88.4% being seen within four hours (well below the 95% target). For major A&E (Type 1) departments just 76.4% of patients were seen within four hours in March 2018 (compared to 85.1% in March 2017), the lowest performance since collection began. Improving the A&E check-in process through the appropriate use of technology may be part of the solution, but declining A&E performance reflects much wider and more challenging pressures on the health and care system as a whole.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing MedCircuit

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MedCircuit is included in 5 Expert Collections, including Artificial Intelligence ( AI ) in Healthcare.

A

Artificial Intelligence ( AI ) in Healthcare

826 items

These healthcare startups are using AI to discover new drugs, remotely monitor patients, securely transfer patient data, and more.

A

Artificial Intelligence

7,340 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,341 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health & Wellness Assessment Tools

2,094 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes providers.

D

Digital Health

9,302 items

Companies that use or incorporate digital technology into their health/wellness product & service offerings. Only those that have raised funding after 01/01/2010

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.